Apr 28, 2020 / 02:30PM GMT
Operator
Hello, and welcome to the Immunovia Q1 Conference Call. My name is Jas, and I'll be your coordinator for today's event. (Operator Instructions) I will now hand you over to your host, Mats Grahn, CEO, to begin today's call. Thank you.
Mats Grahn - Immunovia AB(publ)-CEO
Yes. Good afternoon or good morning wherever you are. It is a pleasure to welcome you to this quarter 1 report from Immunovia. And we will, today, after this slide, also go through the agenda, which is the first quarter highlights, of course. It's our response to the ongoing pandemic. We'll talk about the remaining steps to launch of IMMray PanCan-d, our test for early detection of pancreas cancer; touch on the commercial launch preparation activities; the prospective studies; and then there will be some short information about the upcoming AGM; and we'll finish up with questions.
So the first thing is the highlights that we have had in quarter 1. And we -- the most important thing is, of course, that the verification study of IMMray PanCan-d proceeds as
Q1 2020 Immunovia AB (publ) Earnings Call Transcript
Apr 28, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers